Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.102
Sell
RSI(14)
32.119
Neutral
STOCH(KDJ)(9,3,3)
34.700
Neutral
ATR(14)
1.336
High Vlolatility
CCI(14)
-151.808
Sell
Williams %R
82.305
Oversold
TRIX(12,20)
-0.389
Sell
StochRSI(14)
0.000
Sell
Search
Genpact Ltd
GAdd to Watchlist
32.560USD
-1.910-5.54%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
5.52BMarket Cap
9.86P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Genpact Ltd
Currency: USD Updated: 2026-05-08Key Insights
Genpact Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 157 in the Professional & Commercial Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 48.39.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Genpact Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Genpact Ltd Highlights
StrengthsRisks
Genpact Limited is an agentic and advanced technology solutions company. The Company leverages process intelligence and artificial intelligence to deliver measurable outcomes. The Company's segments include Financial Services, Consumer and Healthcare, and High Tech and Manufacturing. Its Financial Services segment covers services the Company provides to clients in the banking, capital markets and insurance sectors. Its core operations services for these clients include customer onboarding, customer service, collections, and others. Its Consumer and Healthcare segment covers services it provides to clients in the consumer goods, retail, life sciences and healthcare sectors. The core operations services it provides to these clients include demand generation, sensing and planning, supply chain planning and management, and others. The Company's High Tech and Manufacturing segment covers services it provides to clients in the high-tech hardware, high-tech software and manufacturing sectors.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.12%.
Undervalued
The company’s latest PE is 9.86, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 178.57M shares, decreasing 7.78% quarter-over-quarter.
Held by HOTCHKIS & WILEY
Star Investor HOTCHKIS & WILEY holds 91.61K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.45.
Analyst Rating
Based on
14
analysts
Buy
Current Rating
47.122
Target Price
+36.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-08The current financial score of Genpact Ltd is 8.23, ranking 21 out of 157 in the Professional & Commercial Services industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.30B, representing a year-over-year increase of 6.68%, while its net profit experienced a year-over-year increase of 13.10%.
Score
Financials
9.61
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
7.37
Operational Efficiency
7.72
Growth Potential
7.78
Shareholder Returns
8.68
Genpact Ltd's Company Valuation
Currency: USD Updated: 2026-05-08The current valuation score of Genpact Ltd is 6.81, ranking 92 out of 157 in the Professional & Commercial Services industry. Its current P/E ratio is 9.86, which is 155.50% below the recent high of 25.20 and 12.31% above the recent low of 8.65.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 24/157
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-08The current earnings forecast score of Genpact Ltd is 7.29, ranking 102 out of 157 in the Professional & Commercial Services industry. The average price target is 51.50, with a high of 58.00 and a low of 42.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
14
analysts
Buy
Current Rating
47.122
Target Price
+36.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
82
Total
5
Median
9
Average
Company name
Ratings
Analysts
Genpact Ltd
G
14
Block Inc
XYZ
45
PayPal Holdings Inc
PYPL
45
Visa Inc
V
42
Fiserv Ord Shs
FISV
37
Fiserv Inc
FI
37
1
2
3
...
17
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-08The current price momentum score of Genpact Ltd is 6.88, ranking 103 out of 157 in the Professional & Commercial Services industry. Currently, the stock price is trading between the resistance level at 36.30 and the support level at 30.14, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
33.812
Sell
MA10
33.980
Sell
MA20
34.968
Sell
MA50
36.996
Sell
MA100
40.427
Sell
MA200
41.629
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-08The current institutional shareholding score of Genpact Ltd is 10.00, ranking 1 out of 157 in the Professional & Commercial Services industry. The latest institutional shareholding proportion is 105.19%, representing a quarter-over-quarter decrease of 3.00%. The largest institutional shareholder is The Vanguard, holding a total of 15.85M shares, representing 9.34% of shares outstanding, with 3.20% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-08The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Professional & Commercial Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Genpact Ltd is 8.62, ranking 26 out of 157 in the Professional & Commercial Services industry. The company's beta value is 0.61. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.61
VaR
+2.53%
240-Day Maximum Drawdown
+32.87%
240-Day Volatility
+30.91%
Return
Best Daily Return
60 days
+4.55%
120 days
+7.14%
5 years
+15.89%
Worst Daily Return
60 days
-5.57%
120 days
-11.69%
5 years
-15.16%
Sharpe Ratio
60 days
-2.06
120 days
-1.87
5 years
-0.13
Risk Assessment
Maximum Drawdown
240 days
+32.87%
3 years
+41.38%
5 years
+43.05%
Return-to-Drawdown Ratio
240 days
-0.77
3 years
-0.09
5 years
-0.16
Skewness
240 days
+1.23
3 years
+0.86
5 years
+0.55
Volatility
Realised Volatility
240 days
+30.91%
5 years
+28.64%
Standardised True Range
240 days
+3.24%
5 years
+2.93%
Downside Risk-Adjusted Return
120 days
-224.83%
240 days
-224.83%
Maximum Daily Upside Volatility
60 days
+21.26%
Maximum Daily Downside Volatility
60 days
+29.24%
Liquidity
Average Turnover Rate
60 days
+1.47%
120 days
+1.27%
5 years
--
Turnover Deviation
20 days
+76.46%
60 days
+51.97%
120 days
+31.21%
Peer Comparison
Professional & Commercial Services
Genpact Ltd
G
7.78 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Korn Ferry
KFY
8.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
McGrath RentCorp
MGRC
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Barrett Business Services Inc
BBSI
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ennis Inc
EBF
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
ICF International Inc
ICFI
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
